GAM Holding’s Five Prime Therapeutics FPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-16,800
Closed -$633K – 376
2021
Q1
$633K Buy
+16,800
New +$419K 0.03% 255

GAM Holding's FPRX Position: Q2 2021 in Review

GAM Holding sold out of Five Prime Therapeutics (FPRX) in Q2 2021, closing a stake of 16,800 shares — an estimated $633K sold.

GAM Holding first reported a position in FPRX in Q1 2021 and held it in 1 quarter. The position peaked at $633K in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

  • GAM Holding reported no remaining Five Prime Therapeutics position as of Q2 2021 after selling out during the quarter.
  • GAM Holding sold 16,800 Five Prime Therapeutics shares in Q2 2021, an estimated $633K.
  • GAM Holding first reported a position in Five Prime Therapeutics in Q1 2021 and held it in 1 quarter.
  • GAM Holding's Five Prime Therapeutics position peaked at $633K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Five Prime Therapeutics as of Q2 2021.

Based on GAM Holding's 13F filing for Q2 2021, filed 9 Aug 2021.